Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04101357
Title Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech Small Molecules GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | DEU

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Northwestern Medical Faculty Foundation Chicago Illinois 60611 United States Details
Prisma Health-Upstate Cancer Institute Greenville South Carolina 29605 United States Details
University Medical Center Hamburg-Eppendorf - (Recruiting only for part 1B and part 2) Hamburg 20246 Germany Details
Universitaetsklinikum Koeln - (Recruiting only for part 1B and part 2) Koeln 50937 Germany Details
Universitaetsmedizin der Johannes Gutenberg Universitat Mainz KoeR - (Recruiting only for part 1B and part 2) Mainz 55131 Germany Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid 28022 Spain Details
START Madrid - CIOCC. Grupo Hospital de Madrid (HM) - Centro Integral Oncologico Clara Campal (CIOCC) Madrid 28050 Spain Details
Hospital Universitario La Fe de Valencia Valencia 46026 Spain Details
Edinburgh Cancer Research Centre Edinburgh EH4 2XU United Kingdom Details
Sarah Cannon Research Institute London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field